Evaluation of the effect of HIV virus on the digestive flora of infected versus non infected infants

Evaluation of the effect of HIV virus on the digestive flora of infected versus non infected infants

Celine Nguefeu Nkenfou^1,2,&, William Baiye Abange^3,4, Hortense Kamga Gonsu^3,5, Nelly Kamgaing^1,3,5, Emilia Mbamyah Lyonga⁵, Jean de Dieu Anoubissi⁶, Alexis Ndjolo^1,5, Paul Koki^5,7

 

¹Chantal Biya’s International Reference Centre (CBIRC), Centre for HIV/AIDS Prevention and Management, Yaounde, Cameroon, ²Department of Biological Sciences, Higher Teachers Training College, University of Yaounde I, Cameroon, ³University Teaching Hospital, Yaounde, Cameroon, ⁴Catholic University of Central Africa, Yaounde, Cameroon, ⁵Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon, ⁶National AIDS Control Committee, Ministry of Public Health, Yaounde, Cameroon, ⁷Centre Mère Enfant, Fondation Chantal Biya, Yaounde, Cameroon

 

 

^&Corresponding author
Celine Nguefeu Nkenfou, Chantal Biya’s International Reference Centre (CBIRC), Centre for HIV/AIDS Prevention and Management, Yaounde, Cameroon

 

 

 

 

Since the first cases of human immunodeficiency virus (HIV) infection were identified in 1981, the number of infants infected with HIV has increased dramatically in developing countries because the number of HIV-infected women of childbearing age has risen [1]. However, great advances have been made in developed countries to control transmission of the virus from mother to infant. In developing countries some progresses have also been made. Vertically transmitted HIV can cause rapidly progressive, chronically progressive, or adult like disease in which a significant clinical latency period occurs before symptoms appear. The disease progression depends on several factors including the frequency of bacterial infections. Microbial translocation (MT) from the gut has been implicated in driving immune activation, increasing morbidity and mortality in HIV [2]. On the other hand, intestinal flora plays an important role in the defense mechanism in human beings [3]. Specifically, bacterial flora has been shown to play a beneficial role when in equilibrium, but becomes harmful when there is imbalance. While the general dogma is that the placental barrier keeps infants sterile throughout pregnancy, increasing evidence suggests that an infant´s initial bacterial inoculum can be provided by its mother before birth [4, 5] and is supplemented by maternal microbes during the delivery [6] and breastfeeding [7, 8] processes. Soon after birth, infant flora evolves depending on several factors like mode of delivery, nutrition, age and environment [3, 9]. Fooks et al. (2007) [10] reported that the bacterial population in the intestine is quantitatively and qualitatively balanced; each genus has its own growth niche maintaining an "optimal balance" for the physiological performance of the digestive system. However, numerous factors can alter it, either by stimulating beneficial actions through an increase in the number of certain bacteria (Bifidobacteria and Lactobacilli), or by stimulating the proliferation of bacteria considered pathogenic (Clostridia, certain species of Bacteroids, etc.). Knowing that 60% of CD4+ T cells in the human body reside in gut-associated lymphoid tissue, and that the reconstitution of these cell populations and the gut microbial composition is incomplete even under HAART, the human intestine has recently become the focus of attention in HIV research [11]. Moreover, changes in gut microbial composition and function in HIV-positive individuals, aside from being secondary to HIV infection, may also play direct roles in mediating some disease manifestations (recurrent bacterial infections) [11]. The intestinal flora, if well characterized could be balanced before the onset of infection using probiotics. It is for this reason that this research project was initiated with the aim to examine the digestive flora of HIV infected infants born to HIV sero-positive mothers in comparison to that of HIV non-infected infants.

 

 

Study area and population: this study was conducted in Yaounde, Centre Region, the nation's capital city that attract people from other parts of the country and globally for work, education or leisure. Participants were selected based on whether they met the inclusion criteria. HIV patients irrespective of their gender and age were eligible to participate. Excluded from the study were individuals who were on any other antibiotic medication other than prophylatic co-trimoxazole. Participants were randomly recruited into the study from two treatment centers until a convenient sample size was attained. We informed the parents of the participating children of the nature and objectives of the study, and their right of refusal to participate in the study or to withdraw at any time, without jeopardizing their right of access to other health services. After parental consent, fresh stool samples were collected in dry sterile stool container, registered and transported to the Bacteriology Laboratory of Yaounde University Teaching Hospital for analyses using standard operating procedures.

 

Study design and period: this was a cross-sectional study. Briefly, the cases were HIV infected children and the control group were HIV non-infected children aged between 3 months to 24 months. They were enrolled in two HIV treatment centers: Center for Mother and Child, Chantal Biya's Foundation Yaounde and the Pediatric Service-Yaounde of the University Teaching Hospital (YUTH). Controls were enrolled from the Melen neighborhood from April to October 2013.

 

Sampling technique: a time limited sampling technique was used, where patients were consecutively recruited into the study. Participants were enrolled into the study provided their parents/guardians gave their consent and met the inclusion criteria. Our sample size was a convenient one since it was a pilot study.

 

Process of the survey and sample collection: HIV infected children consulting at the study sites on their normal appointment day or for an emergency problem were requested to participate in the study. After obtaining parental informed consent, a questionnaire was administered to each participant's parent by a nurse specifically trained for this task. The participants were instructed on how to produce stool specimen avoiding contamination. Fresh stool sample was collected in a dry sterile stool container. Two ml of blood were collected from each infant to confirm their HIV status. For infants aged less than 18 months, HIV DNA PCR (Amplicor HIV-1DNA test, Roche Diagnostics, Branchburg, NJ) was used. For those aged more than 18 months, the serology test (Determine HIV1/2 test (Alere, Chiba, 270-2214, Japan) coupled to Oraquick test (OraSure Technologies, Thailand)) was done. The fresh stools were transported to the laboratory within 30 minutes for culture. We ensured none of the children participating was taking antibiotic medications at the time of recruitment other the prophylatic co-trimoxazole.

 

Laboratory procedures and stool analysis: using standard operating procedures at the Medical Microbiology/Bacteriology Laboratory of the YUTH, we performed macroscopic examination of the fresh stool samples to note and appreciate the stool consistency, color, odor and lastly observed for the presence of blood or mucus. The fresh stools were then inoculated for the identification of bacteria using specific growth media (Manitol salt agar, MacConkey agar, Blood agar, Shaedler Anaerobe blood agar plus antibiotic inhibitors Vancomycine and Kanamycine, Campybrilliance agar, Reinforced Clostridium differential broth, MRS agar, Bile Aesculin agar. After inoculation, we then incubated at different conditions; aerobic, strict anaerobic and micro-aerophilic conditions. Biochemical tests for microorganism identification was done using conventional classical gallery (oxidase and catalase, urea-indole, Simon citrate fermentation, gas production, lactose and glucose fermentation) and BioMérieux´s API (5 rue des Aqueducs 69290 Craponne, France) commercial identification kits for Gram positive and Gram negative bacteria. For microscopic examination, we performed direct Gram stain to determine, quantify and appreciate the bacteria flora. It should be noted that we performed the culture before microscopic examination to avoid contamination.

 

Data collection: data were collected using a designed questionnaire. Information such as: age, sex, mode of delivery, feeding mode and HIV status were collected. For each participant, their medical records were used to get information concerning their HIV status if available and clinical stage according to the WHO classification. Biological data collected after biochemical characterizations were entered into the database.

 

Statistical analysis: the data collected from the questionnaires and biological analyses were entered in CSPRO version 20.0, for analyses. Statistics performed included the Chi-square test for group comparison. P-value less than 0.05 was considered as statistically significant at 95% confidence interval (CI) according to Fisher's exact test.

 

Administrative and ethical considerations: administrative authorizations were obtained from the UTHY and CMC/CBF. Ethical clearance was obtained from the National Ethical Committee, authorization n^o. 2013/02/N^o026/L/CNERSH/SP. The enrolled infants were those whose parents had signed the proxy consent form. All the participating parents were assured of confidentiality, guaranteed by the attribution of a codified number.

 

 

Description of study population: our population constituted of 80 infants of age between 3 months and 24 months. The majority of the infants recruited during the study were male 49 (61.25%), the rest, 31 (38.75%) were female. From these, we had 33 (41.2%) HIV positive, 15 (18.8%) exposed to HIV but not infected and 32 (40%) negatives (not exposed to HIV). Thirty nine were exclusively breastfed, 24 were under mixed feeding and 17 infants were on exclusive artificial feeding. According to the delivery mode, 66 (82.5%) were born by normal route of which 30 were HIV positive (45%) and 14 (17.5%) were born by caesarean; of which 3 were HIV positive (21%). Thirty two of the HIV infected infants were on ARV treatment (97%). Of the 80 infants, 9 were on antibiotics (4 HIV negative and 5 HIV positive); these infants were excluded from the analyses. Five of the 80 infants had diarrhoea (one HIV negative and 4 HIV positive) and were excluded from the analyses. According to the WHO classification (WHO/HIV/2005.02), of the 33 HIV infected infants, 15 (45.45%) were at stage 4, 11 (33.33%) at stage 3, one (1.25%) at stage 2, and 6 (18.18%) infants were at stage 1. These data are presented in Table 1.

 

Bacteria isolation: seventeen bacteria species were isolated overall in our study population. Lactobacillus spp. (91.3%) Bifidobacterium (81.3%), Campylobacterium (67.5%), Escherichia coli (87.5%) and Streptococcus spp. (70%) were the most abundant. Bacteriodes were identified from only 32% of infants. Pathogenic as well as opportunistic bacteria were also isolated (Clostridium spp. (35%), Staphylococcus aureus (6.3%), Klebsiella spp. (6.3%), Shigella spp. (11.3%).

 

Comparison of bacteria isolated according to the HIV status: among the HIV infected children, Lactobacillus spp. (96.97%), Streptococcus spp. (84.85%) and Bifidobacterium spp. (81.81%) were mostly identified. Whereas in HIV negative infants, high frequency of E. coli (93.62%), Lactobacillus spp. (87.23%) and Bifidobacterium spp. (80.85%) was observed. From HIV infected infants, high diversity (15 different types of bacteria species) was observed with 6 out of 15 being opportunistic and pathogenic bacteria in immune-compromised patients: Shigella spp. (24.24%), Staphylococcus aureus (15.15%), Klebsiella spp. (12.12%), Pseudomonas spp. (3.03%), Acinetobacter spp. (3.03%) and Proteus spp. (3.03%). We observed the absence of Actinomycetes and Enterobacter spp. from HIV positive infants and the absence of Acinetobacter spp. Proteus spp. and Staphylococcus aureus from HIV negative infants. Statistically we found out that opportunistic bacteria (Shigella spp. p<0.001), Klebsiella spp. (p<0.001), and Staphylococcus aureus (p=0.006) were associated with HIV status; as well Clostridium spp. (p=0.009), Enterococcus spp. (<0.001) and Streptococcus spp. (p=0.015) were more frequent in HIV infected infants. There was no statistical difference in the number of infected versus non infected infants harboring Lactobacillus spp. Bifidobacterium spp. and Staphylococcus spp. These data are presented in Table 2. We also observed that many HIV stage 4 infants harbored more opportunistic bacteria than infants of other HIV stages; Acinetobacter spp. Klebsiella spp. Proteus spp. Shigella spp. and Staphylococcus aureus.

 

Exposure to HIV: we did not observe any difference in the digestive flora of HIV exposed and non-infected infants versus non-exposed HIV negative infants.

 

Analyses according to the delivery mode: according to the delivery mode, we isolated more bacteria species from infants born by vaginal route (17 species) than from infants born by caesarean section (8 species). The difference in the frequency of Staphylococcus spp. between infant delivered through the vaginal route and caesarean was statistically significant (p= 0.002, 64.3% versus 22.7%).

 

Analyses according to the feeding options: according to the feeding mode, our study showed that there was no statistically significant difference in the bacteria isolated except for Staphylococcus spp. which was mainly harbored by breastfed infants (88.9%) compared to infants on mixed feeding (11.1%), p=0.005. Bifidobacterium were slightly more frequently isolated from infants on breastfeeding (67.3% versus 32.7% in mixedfed infants) (p=0.059). The difference in Lactobacillus spp. isolated was statistically significant (found mostly from mixedfed infants (64.9%) compared to 35.1% in artificially fed infants) with p=0.024. Likewise, Staphylococcus spp. were mainly isolated from artificially fed infants (75% compared to 25% for mixed fed infants) p=0.041.

 

 

Our work aimed at evaluating the effect of HIV infection on the digestive flora of HIV infected infants using biochemical methods for bacteria identification. From this study 80 participants were enrolled from the CMC/CBF, the UTHY and the community. This was a case-control study where 33 (41.25%) HIV positive infants and 47 (58.75%) HIV negative infants were enrolled. 32 of the HIV infected infants were on ARV treatment while only one was still waiting initiation which should tally with the WHO 2010 recommendations: "Start ART immediately upon diagnosis." Unfortunately most of the HIV positive infants (78.78%) were already at Stage 3-4 based on the WHO classification. This may imply that they were initiated on ART treatment very late; or that they were initiated with wrong drugs due to the acquisition of drug resistant strains from their mothers. We looked at bacteria shed in the stools, which is an easy to collect biological material. Bacteria make up most of the flora in the colon and up to 60% of the dry mass of feces [12, 13]. An estimate of 300 to 1000 different species live in the gut [14, 15], with most estimated at about 500 [16-18]. However, it is probable that 99% of the bacteria come from about 30 or 40 species [12]. According to the delivery mode, we isolated more bacteria species from infants born by vaginal route than from infants born by caesarean section. The difference in the frequency of Staphylococcus spp. between infant delivered through the vaginal route and caesarean was statistically significant (p= 0.002, 64.3% versus 22.7%). A number of studies have shown a relationship between the mode of delivery and the colonization of the infant intestine [19-24]. According to the feeding mode, our study showed a differential frequency in harboring Staphylococcus spp. Bifidobacterium and Lactobacillus spp. This is in agreement with other studies that showed a relationship between the digestive flora and the mode of nutrition [9, 19, 25, 26]. We will like to clarify here that formula feeding in Cameroon is based on two main types: plain and enriched. In Cameroon, pediatric milks (0-6 months) are enriched with probiotics (Lactobacillus or Bifidobacteria) and prebiotics (mainly the fructo-oligosaccharides and the galacto-oligosaccharides). These milks represent more than 50% on the market.

 

The diversity of bacteria identified was analysed according to the HIV status of the infants. Qualitatively we isolated more bacteria in HIV positive children (15 different species of bacteria) than in exposed HIV negative infants and non-exposed negative (11 different species of bacteria). Statistically, Clostridium spp. Enterococcus spp. Stapylococcus aureus and Streptococcus spp. were significantly associated with HIV positive status (p=0.009, P=0, P=0.006, P=0.015 respectively). The number of bacteria isolated increases from stage 1 to stage 4 (from 11 to15). HIV infection negates both gut bacteria and epithelial barriers, then propagate the infection [27]. There was an observed shift in gut composition from protective species to pro-inflammatory disease-inducing bacterial species that promote viral replication and chronic immune activation. Bacteroides species also known to benefit their host by excluding potential pathogens from colonizing the gut were least frequently isolated from infected infants. This dysbiosis observed in infants has also been observed in adults [28-30]. Five (15.15%) of the 33 HIV infected infants were on antibiotics and 4 (8.51%) of 47 HIV negative were also on antibiotics with no significant difference in bacteria flora. Normally, all the HIV infected infants were supposed to be on cotrimoxazole until 5 years old according to WHO Guidelines on cotrimoxazole prophylaxis for HIV-related infections among infants, adolescents and adults: recommendations for a public health approach. Among the HIV infected children, Lactobacillus spp. (96.97%), Streptococcus spp. (84.85%) and Bifidobacterium spp. (81.81%) were mostly identified. Whereas in HIV negative infants, high frequency of E. coli (93.62%), Lactobacillus spp. (87.23%) and Bifidobacterium spp. (80.85%) was observed. In a study done on younger infants (few days of life), the main bacterial groups found in HIV negative infant's faeces were Bifidobacterium, Streptococci and Enterococci [31]. This may be due to age, feeding option and environment.

 

In our study population, opportunistic bacteria (Shigella spp. Klebsiella spp. Proteus spp. Pseudomonas spp. and Staphylococcus aureus) were significantly associated with HIV positive infants. Their immune-compromised state promotes the proliferation of these opportunistic bacteria. Bacterial infections are the most common opportunistic infections in HIV. Since the advent of highly active antiretroviral therapy (HAART), the incidence of these infections is on the decline. However, globally there is a significant lack of access to care among HIV patients because of limited drug availability especially pediatric formulations. Furthermore, non-compliance and drug resistance can hinder viral suppression, predisposing patients to opportunistic infections. In other not to bias the result obtained from our study we mostly enrolled infants who presented at the hospital for their routine follow-up (less or no clinical signs and symptoms). This is why we had 11.25% on antibiotics, 6.25% with diarrhea and 3.75% with constipation; which were excluded from our analyses. So our study was limited by lack of possibility to cover all the bacteria living in the GIT, and thus was confined to those that could be cultured. Not all the species in the gut have been identified because most cannot be cultured [15], and making identification difficult. An effort to better describe the microflora of the gut and other body fluids using newly developed non-culture based technologies [32] has been achieved. A project termed the "Human Microbiome Project" [33] has been initiated and takes advantage of new, high-throughput technologies to characterize the human microbiome.

 

 

We aimed at looking at the effect of HIV infection on the digestive flora of HIV infected infants. Our results showed that HIV infected infants harbor qualitatively more bacteria than HIV non-infected infants. We found that, as HIV disease progresses the digestive flora changes qualitatively and also that as the disease advances (Stage 1-4) the number of opportunistic bacteria also increases. HIV infected infants harbor more opportunistic bacteria than non-infected infants. The delivery mode affected the flora of HIV infected infants compared to non-infected infants (Staphylococcus spp.). As well, the feeding mode affected the flora (Staphylococcus spp. and Lactobacillus). This is the first study to our knowledge done on the flora of HIV positive versus negative infants in Cameroon. Data obtained highlights that bacteria present in infants' gastrointestinal tract are important parameters in the progression of HIV/AIDS disease. Targeting the balance of digestive flora is thus crucial for the management and effective treatment of HIV co-morbidities. For limited resources countries, stool culture could be used for better management of HIV infected infants in order to reduce the gut disorders.

 

 

All authors declare no competing interests.

 

 

Nkenfou did study design, data analyses, manuscript preparation, approval and submission. Abange did samples and data collection, data analyses, approval of the manuscript. Gonsu did data analyses, manuscript review and approval. Kamgaing did data analyses, manuscript review and approval. Lyonga did data analyses, manuscript review and approval. Anoubissi did data analyses, manuscript review and approval. Ndjolo did study supervision, manuscript review and approval. Koki did study supervision, manuscript review and approval. All the authors have read and agreed to the final manuscript.

 

 

We will like to acknowledge the contribution of the parents and the infants who participated in this study.

 

 

Table 1: socio-demographic presentation of the study population

Table 2: comparison of selected bacteriological profiles by HIV status

 

 

1. Rivera Delia M, Frye Richard E. Pediatric HIV infection. Medscape medical news. Accessed July 15, 2014.


2. Fitzgerald Felicity, Harris Kathryn, Doyle Ronan, Alber Dagmar, Klein Nigel. Evidence That Microbial Translocation Occurs in HIV-Infected Children in the United Kingdom. AIDS Res Hum Retroviruses. 2013; 29(12): 1589-1593. PubMed | Google Scholar


3. Bourlioux Pierre, Berthold Koletzko, Guarner Francisco & Braesco Veronique. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. Am J Clin Nutr. 2003 Oct; 78(4): 675-83. PubMed | Google Scholar


4. Jimenez Esther, Marin Maria L, Martin Rocio, Odriozola Juan M, Olivares Monica, Xaus Jordi et al. Is meconium from healthy newborns actually sterile. Res Microbiol. 2008 Apr; 159(3): 187-93: 187-193. Epub 2008 Jan 11. PubMed | Google Scholar


5. Bearfield Caroline, Davenport Elisabeth S, Sivapathasundaram Vythil, Allaker Robert P. Possible association between amniotic fluid micro-organism infection and microflora in the mouth. BJOG. 2002; 109(5): 527-533. PubMed | Google Scholar


6. Dominguez-Bello Maria G, Costello Elisabeth K, Contreras Monica, Magris Magda, Hidalgo Glida, Fierer Noah et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010; 107(26): 11971-11975. Epub 2010 Jun 21. PubMed | Google Scholar


7. Martin Virginia, Maldonado-Barragan Antonio, Moles Lauro, Rodriguez-Banos Mercedes, Campo Rosa Del, Fernández Leonides et al. Sharing of bacterial strains between breast milk and infant feces. J Hum Lact. 2012; 28(1): 36-44. PubMed | Google Scholar


8. Grönlund MM, Gueimonde M, Laitinen K, Kociubinski G, Gronroos T, Salminen S et al. Maternal breast-milk and intestinal Bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy. 2007; 37(12): 1764-1772. PubMed | Google Scholar


9. Fanaro Silvia, Chierici Roberta, Guerrini Pieto, Vigi Vittorio. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl. 2003; 91(441): 48-55. PubMed | Google Scholar


10. Fooks Laura J, Gibson Glenn R. Probiotics as modulators of the gut flora. Br J Nutr. 2002; 88(Suppl 1): S39-S49. PubMed | Google Scholar


11. Zilberman-Schapira Gili, Zmora Niv, Itav Shlomik, Bashiardes Stavros, Elinav Hila, Elinav Eran. The gut microbiome in human immunodeficiency virus infection. BMC Med. 2016; 14(1): 83. PubMed | Google Scholar


12. Beaugerie Laurent and PetitJean-Claude. Antibiotic-associated diarrhoea. Best Practice & Research Clinical Gastroenterology. 2004; 18(2): 337-52.


13. Stephen Alison M, Cummings John H. The Microbial Contribution to Human Faecal Mass. Journal of Medical Microbiology. 1980; 13(1): 45-56. PubMed | Google Scholar


14. Guarner Francisco, Malagelada Juan-R. Gut flora in health and disease. The Lancet. 2003; 361(9371): 512-519. PubMed | Google Scholar


15. Sears Cynthia LA. A dynamic partnership: celebrating our gut flora. Anaerobe. 2005; 11(5): 247-251. Epub 2005 Jun 27 PubMed | Google Scholar


16. O'Hara Ann M, Shanahan Fergus. The gut flora as a forgotten organ. EMBO Reports. 2006; 7(7): 688-693. PubMed | Google Scholar


17. Steinhoff Ulrich. Who controls the crowd? New findings and old questions about the intestinal microflora. Immunology Letters. 2005; 99(1): 12-16. Epub 2005 Jan 21. PubMed | Google Scholar


18. Gibson Glenn R. Fibre and effects on probiotics (the prebiotic concept). Clinical Nutrition. 2004; 1(2): 25-31. Epub 2013 Feb 11. Google Scholar


19. Azad Meghan B, Konya Theodore, Maughan Heather, Guttman David S, Field Catherine J, Chari Radha S et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. Canadian Medical Association Journal. 2013; 185(5): 385-394. PubMed | Google Scholar


20. Neu Josef, Rushing Jona. Cesarean versus vaginal delivery: long term infant outcomes and the hygiene hypothesis. Clin Perinatol. 2011; 38(2): 321-331. PubMed | Google Scholar


21. Biasucci Giacomo, Benenati Brian, Morelli Lorenzo, Bessi Elena, Boehm Guenther. Cesarean Delivery May Affect the Early Biodiversity of Intestinal Bacteria. J Nutr. 2008; 138(9): 1796S-1800S. PubMed | Google Scholar


22. Salminen Seppo, Gibson Glenn R, McCartney Anne L, Isolauri Erika. Influence of mode of delivery on gut microbiota composition in seven years old children. Gut. 2004; 53(9): 1388-1389. Google Scholar


23. Grönlund Minna Madja, Lehtonen Olli Pekka, Eerola Erkki, Kero Pentti. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after caesarean delivery. J Pediatr Gastroenterol Nutr. 1999; 28(1): 19-25. PubMed | Google Scholar


24. Orrhage Kerstin, Nord Carl Erik. Factors controlling the bacterial colonization of the intestine in breast fed infants. Acta Paediatr. 1999; 88(430): 47-57. PubMed | Google Scholar


25. Harmsen Hermie J, Wildeboer-Veloo Alida C, Raangs Gerwin C, Wagendorp Arjen A, Klijn Nicolette, Bindels Jacques G, Welling Gjalt W. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000; 30(1): 61-67. PubMed | Google Scholar


26. Rubaltelli Firmino F, Biadaioli Robert, Pecile Patricia & Nicoletti Pierluigi. Intestinal flora in breast and bottle-fed infants. J Perinat Med. 1998; 26(3): 186-191. PubMed | Google Scholar


27. Nwosu Felix Chinweije, Avershina Ekaterina, Wilson Robert, Rudi Knut. Gut microbiota in HIV infection: implication for disease progression and management. Gastroenterology Research and Practice. 2014; 2014: 803185. PubMed | Google Scholar


28. Lozupone Catherine A, Li Marcella, Campbell Thomas B, Flores Sonia C, Linderman Derek, Gebert Matthew J et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe. 2013; 14(3): 329-339. PubMed | Google Scholar


29. Lozupone CA, Rhodes ME, Neff CP, Fontenot AP, Campbell TB, Palmer BE. HIV-induced alteration in gut microbiota: driving factors, consequences and effects of antiretroviral therapy. Gut Microbes. 2014; 5(4): 562-570. Epub 2014 Jul 31. PubMed | Google Scholar


30. Vujkovic-Cvijin Ivan, Dunham Richard M, Iwai Shoko, Maher Cyrus M, Albright Rebecca G, Broadhurst Mara J et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med. 2013; 5(193): 193ra191. PubMed | Google Scholar


31. Gonzalez Raquel, Maldonado Inacio, Fumado Victoria, Sacoor Charfudin, Macete Eusebio, Alonso Pedro L et al. Breast milk and gut microbiota in African mothers and infants from an area of high HIV prevalence. PLoS One. 2013; 8(11): e80299. eCollection 2013. PubMed | Google Scholar


32. Dethlefsen Les, McFall-Ngai Margaret, Relman David A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007; 449(7164): 811-8. PubMed | Google Scholar


33. The NIH HMP Working Group, Peterson Jane, Garges Susan, Giovanni Maria, McInnes Pamela, Wang Lu et al. The NIH Human Microbiome Project. Genome Res. 2009; 19(12): 2317-2323. Epub 2009 Oct 9. PubMed | Google Scholar